Lupamik 500 Injection is a prescription drug, available for use as Injection. Urinary Tract Infection are some of its major therapeutic uses. The alternative uses of Lupamik 500 Injection have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Lupamik 500 Injection. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Lupamik 500 Injection as well, which are listed below. Normally, these side effects of Lupamik 500 Injection are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
In addition, Lupamik 500 Injection's effect is Severe during pregnancy and Unknown for lactating mothers. In addition, Lupamik 500 Injection's effects on the liver, heart and kidney are discussed below in the Lupamik 500 Injection related warnings section.
Lupamik 500 Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Dehydration, Parkinson's Disease, Hearing Loss are examples of such conditions. Other conditions have been mentioned below in the Lupamik 500 Injection contraindications section.
Drug reaction of Lupamik 500 Injection with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Lupamik 500 Injection, it is important to know that it is safe while driving, and is habit-forming.
Lupamik 500 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Lupamik 500 Injection is used -
Moderate
Mild
Unknown
Is the use of Lupamik 500 Injection safe for pregnant women?
Pregnant women may get severe side effects after taking Lupamik. If you are pregnant, do not take Lupamik without a doctor's advice.
Is the use of Lupamik 500 Injection safe during breastfeeding?
Information about safety of Lupamik for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Lupamik 500 Injection on the Kidneys?
Lupamik may have severe effects on your kidney, so do not take it without consulting your doctor.
What is the effect of Lupamik 500 Injection on the Liver?
Lupamik may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Lupamik 500 Injection on the Heart?
Lupamik may have mild side effects on the heart. Most people will never see any effect on the heart.
Lupamik 500 Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Lupamik 500 Injection unless your doctor advises you to do so -
Is this Lupamik 500 Injection habit forming or addictive?
Lupamik 500 Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Lupamik 500 Injection will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Lupamik 500 Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Lupamik 500 Injection cannot treat any kind of mental disorder.
Interaction between Food and Lupamik 500 Injection
Taking Lupamik 500 Injection with food does not harm your health.
Interaction between Alcohol and Lupamik 500 Injection
No research has been done on this till date. Therefore, it is not known what the effect of taking Lupamik 500 Injection with alcohol will be.
Yes, Lupamik is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as decreased urination, itching, irritation, and hearing loss. If you experience above-mentioned side after consuming this medicine then inform your doctor and follow his/her instructions.
Lupamik can be safely taken as prescribed by your doctor. Do not discontinue the medicine suddenly or take it longer than prescribed duration.
Discontinuing Lupamik on your own can increase the chances of bacterial resistance and infection relapse. It is recommended that you always consult your doctor if you have decided to discontinue this medicine.
Occasionally, Lupamik can cause drug-induced thrombocytopenia (blood clot formation in the vessel). However, if you experience severe thrombocytopenia after taking this medicine, please immediately seek medical help.
Yes, Lupamik is nephrotoxic. Nephrotoxicity depends on dose and duration of therapy. Thus, nephrotoxicity is likely to occur if Lupamik taken a high dose for a long time or may occur if the drug is given to a patient that already suffer from kidney problem. Nephrotoxicity associated with this drug may reduce or minimize by taking some precaution before consuming this drug like monitor kidney functions regularly and do not take it in high doses. Avoid taking Lupamik with another nephrotoxic drug. If you notice any urine discoloration after taking this drug then inform your doctor immediately.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137